|
Market Closed -
Nasdaq
04:00:00 2026-10-21 pm EDT
|
5-day change | 1st Jan Change | ||
| 156.31 USD | -2.05% |
|
-3.64% | -14.42% |
| Oct. 14 | Axsome Shows Valuation Disconnect Ahead of Q3, RBC Says | MT |
| Oct. 08 | RBC Trims Price Target on Axsome Therapeutics to $295 From $297, Keeps Outperform Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.05% | -3.64% | -23.93% | -34.03% | -14.42% | +18.97% | +143.28% | +282.93% | +2,012.30% | 8.19B | |
| -1.01% | +5.13% | +9.09% | +8.11% | +18.24% | +58.93% | +117.36% | +426.91% | +1,523.96% | 1,133B | |
| -0.61% | +1.52% | -4.34% | +2.86% | +24.56% | +34.34% | +68.48% | +57.76% | +127.24% | 621B | |
| -1.48% | +0.47% | +7.68% | +11.21% | +24.64% | +23.08% | +94.76% | +161.86% | +367.04% | 503B | |
| -0.68% | +2.58% | +6.98% | +17.18% | +18.68% | +38.86% | +63.97% | +9.47% | +68.83% | 379B | |
| +1.07% | +1.70% | +0.25% | +18.71% | +42.39% | +71.06% | +45.98% | +84.65% | +144.90% | 370B | |
| +0.46% | +1.35% | +9.57% | +1.80% | +16.42% | +21.69% | +51.01% | +64.56% | +71.05% | 292B | |
| -0.18% | -0.82% | -0.62% | -0.85% | -8.67% | +0.43% | +24.69% | +40.00% | +159.62% | 262B | |
| -0.14% | +2.87% | +11.49% | +19.69% | +33.92% | +45.56% | +57.22% | +109.74% | +176.54% | 237B | |
| -1.88% | +0.02% | +2.00% | +17.88% | +25.12% | +23.77% | +97.39% | +129.24% | +106.72% | 190B | |
| +0.12% | -0.55% | +1.24% | -18.00% | -19.45% | -23.72% | -61.59% | -22.65% | +85.75% | 174B | |
| -0.86% | +2.19% | +7.61% | +19.69% | +19.88% | +20.12% | -2.61% | -30.35% | -7.24% | 170B | |
| +1.92% | +5.22% | +2.70% | +8.82% | +15.70% | +23.05% | +44.95% | +180.36% | +549.48% | 133B | |
| -0.91% | +3.10% | -2.40% | +0.31% | +13.31% | +37.22% | +8.25% | +5.73% | +22.19% | 125B | |
| -1.42% | +3.99% | +14.56% | +22.52% | +23.80% | +28.99% | +124.27% | +390.13% | +530.63% | 118B | |
| +0.37% | +0.45% | -1.52% | -1.75% | +2.88% | +13.59% | +28.35% | +5.69% | -8.49% | 100B | |
| -0.79% | +1.21% | -1.83% | -4.96% | -11.71% | -15.79% | -25.71% | -14.19% | +5.53% | 98.91B | |
| +1.54% | +8.62% | +42.14% | +312.02% | +733.54% | +794.18% | +205.73% | -27.61% | - | 98.14B | |
| -0.22% | +3.51% | +0.94% | +19.32% | +4.38% | +39.07% | -0.35% | +41.50% | +121.62% | 80.45B | |
| +1.12% | +0.91% | +8.56% | +5.59% | +17.90% | +25.53% | -0.21% | -28.58% | +46.87% | 69.41B | |
| Average | -0.13% | +2.99% | +4.51% | +21.31% | +49.06% | +63.95% | +54.26% | +93.36% | +321.29% | 258.17B | |
| Weighted average by Cap. | +0.17% | +3.65% | +5.33% | +14.36% | +32.07% | +49.53% | +67.80% | +150.61% | +469.05% |
- Stock Market
- Stocks
- AXSM Stock
- Sector Axsome Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
